27 August 2026
Rasonque, a pancreatic cancer treatment from Revolution Medicines, offers a new option for advanced patients. Discover its benefits.
11 June 2026
Uncover the potential of mRNA vaccines that show promise for personalized cancer treatments that target tumor cells effectively.
9 June 2026
Daraxonrasib Pancreatic Cancer Pill nearly doubled survival in metastatic PDAC, beating second-line chemo with fewer discontinuations.
16 April 2026
Daraxonrasib pancreatic cancer trial results show that Revolution Medicines' new therapy is doubling survival rates and reshaping oncology.